Friday, July 10, 2026

Drug profile · INN

lutetium (177lu) chloride

lutetium (177lu) chloride (ENDOLUCINBETA) is a diagnostic agent.

EMA: approved Various (V10) V10X
Patents linked 0
Pipeline programs 6
News articles 0
Drug details — lutetium (177lu) chloride
Class
Various (V10)
Route
Patents
0
Programs
6
Data quality
0.83

Quick answer

lutetium (177lu) chloride (ENDOLUCINBETA) is a diagnostic agent.

Key facts

INN lutetium (177lu) chloride
Brand ENDOLUCINBETA
Mechanism Diagnostic agent
Therapeutic class Various (V10)
ATC code V10X

Mechanism of action

Diagnostic agent

Approval history

Authority Status Date
EMA approved

Pipeline programs

  1. 177Lu PSMA I&T solution for injection Phase 2 · Createrna Science and · Recurrent grade 3 and grade 4 glioma
  2. 177Lu girentuximab Phase 2 · Telix Innovations · Advanced Cancer
  3. Lutetium (177Lu) rhPSMA-10.1 injection Phase 2 · Blue Earth Diagnostics · Metastatic castration-resistant prostate cancer (mCRPC)
  4. BET-PSMA-001 Phase 1 · Blue Earth Diagnostics · PSMA-positive non-curative metastatic castration-resistant p
  5. Endo Tool Phase 1 · United Therapeutics Europe · Burns
  6. extended release niacin Unknown · United Therapeutics Europe · HIV Infections

Related & competitor drugs

  1. besilesomab Various (V09)
  2. deferasirox Various (V03)
  3. ferric citrate coordination complex Various (V03)
  4. folic acid Various (V04)
  5. sevelamer carbonate Various (V03)
  6. sugammadex sodium Various (V03)

Frequently asked questions

What is lutetium (177lu) chloride?

lutetium (177lu) chloride (ENDOLUCINBETA) is a diagnostic agent.

What is the brand name for lutetium (177lu) chloride?

ENDOLUCINBETA is a marketed brand name for lutetium (177lu) chloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.